Since the change in the law in Switzerland on August 1, 2022, doctors have been allowed to prescribe medical cannabis to their patients without a special authorization from the federal government.
The demand for medical cannabis has steadily increased in recent years as more and more patients benefit from the positive therapeutic effects of this natural plant.
As physicians, you play a central role in healthcare and have the opportunity to make a significant contribution to improving your clients' quality of life.
Astrasana Holding AG is committed to ensuring that as many doctors as possible throughout Switzerland facilitate access to medical cannabis for their patients and prescribe cannabis-based medicines accordingly.
Register with us and get access to detailed information. This includes therapy indications, legal requirements for reimbursement, clinical studies and much more.
In addition, Astrasana regularly hosts educational events where cannabis-specialized physicians serve as speakers to explain the opportunities and possibilities.